Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1237820

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1237820

Implantable Medical Devices Market Size, By Product, By Type, By Nature of Device, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

PUBLISHED:
PAGES: 492 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Implantable Medical Devices Market is expected to expand positively through 2032 owing to the surging preference for biomaterials to accomplish better biocompatibility as well as outcomes. Moreover, a slew of technological innovations in implantable medical devices is expected to boost product performance and clinical results.

To illustrate, Coherent Corporation in early 2023, launched a fully automated laser system, AP 530 S, for marking and texturing implantable medical devices. The process is contactless, which eliminates the risk of contamination and ensures improved level of uniformity and quality for medical devices.

Prominent companies are creating high-end implantable technologies as well as data monitoring applications that offer clinical data regarding patient health and device performance. For instance, in March 2022, Johnson & Johnson revealed that its DePuy Synthes division has introduced two cutting-edge knee implants, the ATTUNE Cementless Fixed Bearing Knee as well as the ATTUNE Medial Stabilized Knee System. The novel product launch helped the firm improve its product portfolio and boost its revenue share.

The implantable medical devices market has been divided in terms of product, type, nature of devices, end-use, and region.

Based on product, the plastic surgery segment is slated to grow at more than 10.5% CAGR from 2023 to 2032. Increased awareness of physical attributes as well as the burgeoning preference for a specific beauty standard is expected to drive market expansion.

With respect to end-use, the hospitals segment is anticipated to attain sizable market expansion over the review years fueled by the deployment of cutting-edge implantable devices in hospital settings that deliver improved outcomes. Other factors favorably influencing the expansion of the hospital segment include rising illness screening programs, growing hospitalizations for chronic disorder treatments, such as heart and orthopedic conditions, as well as rising admissions for heart and orthopedic problems.

From the regional perspective, the Latin America implantable medical devices market is speculated to grow at more than 10% CAGR from 2023 to 2032. The regional expansion is expected to be driven by expanding population base throughout the region and an increase in medical tourism. The demand for technologically improved equipment for the treatment of various diseases is also expected to drive market expansion in the LATAM region.

As per reports, Mexico stands as the second most popular destination for medical tourism worldwide, with an influx of 1.4 million to 3 million people to take advantage of inexpensive treatment.

Product Code: 4483

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 COVID-19 impact analysis at global level
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Implantable medical devices industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Type trends
    • 2.1.4 Nature of device trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Implantable Medical Devices Industry Insights

  • 3.1 Industry landscape, 2018 - 2032
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of chronic diseases across the globe
      • 3.2.1.2 Scarcity of organ donors
      • 3.2.1.3 Technological advancement in developed nations
      • 3.2.1.4 Rising government funding for implantable medical devices in developed countries
      • 3.2.1.5 Increasing focus on development of microelectronics and implantable sensors
      • 3.2.1.6 Growing adoption of biomaterials for better biocompatibility and outcomes
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of devices
      • 3.2.2.2 Stringent regulations for active implantable medical devices
      • 3.2.2.3 Considerable rate of post-procedural complications
      • 3.2.2.4 High number of recalls of implantable medical devices
  • 3.3 Growth potential analysis
    • 3.3.1 By product
    • 3.3.2 By type
    • 3.3.3 By nature of devices
    • 3.3.4 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
    • 3.5.1 U.S.
    • 3.5.2 Europe
    • 3.5.3 Asia Pacific
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 Pricing analysis, 2021
  • 3.9 Trend in adoption of materials for manufacture of implantable medical devices
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Competitive dashboard, 2021
  • 4.3 Company matrix analysis, 2021
  • 4.4 Company market share analysis, 2021

Chapter 5 Implantable Medical Devices Market, By Product

  • 5.1 Key segment trends
  • 5.2 Cardiovascular
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Pacemaker
      • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.3 Implantable cardiac defibrillators (ICDs)
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Cardiac Resynchronization Therapy (CRT)
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.5 Stents
      • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.6 Ventricular assist devices
      • 5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.7 Implantable cardiac monitors (ICM)
      • 5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.8 Others
      • 5.2.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Orthopedic
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Joint reconstruction
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Trauma fixation devices
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 Spinal devices
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 Others
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Ophthalmology
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.2 Intraocular lenses & glaucoma implants
      • 5.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.4.3 Others
      • 5.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Plastic surgery
    • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.2 Breast implants
      • 5.5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.5.3 Gluteal implants
      • 5.5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.6 Neurology
    • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.2 Deep brain stimulators
      • 5.6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.6.3 Others
      • 5.6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.7 Dental
    • 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.2 Dental implants
      • 5.7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.3 Dental crowns & abutment
      • 5.7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.7.4 Others
      • 5.7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.8 Others
    • 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Implantable Medical Devices Market, By Type

  • 6.1 Key segment trends
  • 6.2 Treatment
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Diagnostic
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Implantable Medical Devices Market, By Nature of Devices

  • 7.1 Key segment trends
  • 7.2 Active
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Static/Non-active/Passive
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Implantable Medical Devices Market, By End-use

  • 8.1 Key segment trends
  • 8.2 Hospitals
    • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.3 Multi-specialty centers
    • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.4 Ambulatory surgical centers
    • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.5 Clinics
    • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 8.6 Others
    • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Implantable Medical Devices Market Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Poland
    • 9.3.7 Austria
    • 9.3.8 Switzerland
    • 9.3.9 Sweden
    • 9.3.10 Denmark
    • 9.3.11 Slovakia
    • 9.3.12 Czech Republic
    • 9.3.13 Finland
    • 9.3.14 Benelux
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Taiwan
    • 9.4.7 Indonesia
    • 9.4.8 Thailand
    • 9.4.9 Vietnam
    • 9.4.10 Cambodia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Medtronic Plc
  • 10.2 Zimmer Biomet
  • 10.3 AbbVie Inc. (Allergan plc)
  • 10.4 MicroPort Scientific Corporation
  • 10.5 Stryker Corporation
  • 10.6 Smith & Nephew plc
  • 10.7 Boston Scientific Corporation
  • 10.8 Abbott Laboratories, Inc
  • 10.9 Alcon Laboratories
  • 10.10 Bausch & Lomb
  • 10.11 Mindray Medical International Limited
  • 10.12 POLYTECH Health & Aesthetics
  • 10.13 MED-EL GmbH
  • 10.14 Demant A/S
  • 10.15 Advanced Bionics Corporation (Sonova Holdings AG)
  • 10.16 Cochlear Limited
  • 10.17 W. L. Gore & Associates, Inc
  • 10.18 Johnson & Johnson
  • 10.19 Henry Schein, Inc
  • 10.20 BIOTRONIK SE & Co. KG
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!